Considering the participation of NF-κB signaling pathway in E6-mediated HNSCC progression, we investigated whether SLPI could reverse the E6-induced activation of NF-κB signaling pathway. The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.